StockData
Regencell Bioscience Holdings Ltd logo

Regencell Bioscience Holdings Ltd (RGC) stock

RGCNasdaqMedicinal Chemicals & Botanical Products
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 7, 2026Score 5/30
$4.69+0.14 (+3.08%)

Close on Nov 18, 2026Market cap $2.33BP/E –Yield –

Regencell Bioscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Regencell Bioscience's price to book ratio was 201.0× on Nov 11, 2026, against 11.4× a year earlier. Over the last 3 years it ranged from 3.6× to 249.3×, with a median of 16.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026201.0×+106.0
2025Apr 30, 202595.0×+87.2
2024Dec 31, 20247.8×−3.5
2023Dec 29, 202311.4×−9.9
2022Dec 30, 202221.3×–

More Regencell Bioscience figures

See a number that looks wrong?